(Q36525240)

14 August 2017

1 reference

title

Pathogenesis of graves ophthalmopathy: implications for prediction, prevention, and treatment (English)

1 reference

14 August 2017

1 reference

Graves' ophthalmopathy

1 reference

James A Garrity

1

1 reference

14 August 2017

Rebecca S Bahn

series ordinal

2

1 reference

14 August 2017

language of work or name

English

0 references

publication date

1 July 2006

1 reference

American Journal of Ophthalmology

14 August 2017

1 reference

14 August 2017

142

1 reference

14 August 2017

1

1 reference

14 August 2017

147-153

1 reference

Evidence for enhanced adipogenesis in the orbits of patients with Graves' ophthalmopathy

14 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3960010

Graves' dermopathy and acropachy are markers of severe Graves' ophthalmopathy

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3960010

Infections and anti–tumor necrosis factor α therapy

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3960010

Impact of smoking on the response to treatment of thyroid associated ophthalmopathy

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3960010

Clinical review 157: Pathophysiology of Graves' ophthalmopathy: the cycle of disease

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3960010

Clinical outcome in 22 patients with rheumatoid arthritis treated with B lymphocyte depletion

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3960010

Stimulation of adipogenesis, peroxisome proliferator-activated receptor-gamma (PPARgamma), and thyrotropin receptor by PPARgamma agonist in human orbital preadipocyte fibroblasts

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3960010

Association of thyrotrophin receptor antibodies with the clinical features of Graves' ophthalmopathy

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3960010

Activators of peroxisome proliferator-activated receptor gamma have depot-specific effects on human preadipocyte differentiation.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3960010

Regulation of lipolysis during the neonatal period. Importance of thyrotropin

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3960010

Soluble interleukin-1 receptor antagonist serum levels in smokers and nonsmokers with Graves' ophthalmopathy undergoing orbital radiotherapy.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3960010

More on smoking habits and Graves' ophthalmopathy

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3960010

Reevaluating thyrotropin receptor-induced mouse models of graves' disease and ophthalmopathy.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3960010

Relative overexpression of macrophage-derived cytokines in orbital adipose tissue from patients with graves' ophthalmopathy

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3960010

Immunoglobulin activation of T cell chemoattractant expression in fibroblasts from patients with Graves' disease is mediated through the insulin-like growth factor I receptor pathway

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3960010

Adipose thyrotrophin receptor expression is elevated in Graves' and thyroid eye diseases ex vivo and indicates adipogenesis in progress in vivo

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3960010

Peroxisome proliferator-activated receptor-gamma in thyroid eye disease: contraindication for thiazolidinedione use?

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3960010

Orbital fibroblast heterogeneity may determine the clinical presentation of thyroid-associated ophthalmopathy

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3960010

Igs from patients with Graves' disease induce the expression of T cell chemoattractants in their fibroblasts

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3960010

Human orbital fibroblasts are activated through CD40 to induce proinflammatory cytokine production.

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3960010

TSH-R expression and cytokine profile in orbital tissue of active vs. inactive Graves' ophthalmopathy patients

21 September 2018

1 reference

12 December 2020

Treatment of rheumatoid arthritis by selective inhibition of T-cell activation with fusion protein CTLA4Ig

1 reference

12 December 2020

Elephantiasic pretibial myxedema: insight into and a hypothesis regarding the pathogenesis of the extrathyroidal manifestations of Graves' disease

1 reference

12 December 2020

Exophthalmos caused by excessive fat: CT volumetric analysis and differential diagnosis

1 reference

12 December 2020

Methimazole, but not betamethasone, prevents 131I treatment-induced rises in thyrotropin receptor autoantibodies in hyperthyroid Graves' disease

1 reference

12 December 2020

Smoking and risk of Graves' disease

1 reference

12 December 2020

Pathogenesis of Graves' ophthalmopathy

1 reference

12 December 2020

Detection of TSH receptor RNA in cultured fibroblasts from patients with Graves' ophthalmopathy and pretibial dermopathy

1 reference

12 December 2020

Leukoregulin is a potent inducer of hyaluronan synthesis in cultured human orbital fibroblasts

1 reference

12 December 2020

Superoxide radical production stimulates retroocular fibroblast proliferation in Graves' ophthalmopathy

1 reference

12 December 2020

Relation between therapy for hyperthyroidism and the course of Graves' ophthalmopathy

1 reference

12 December 2020

Thyrotropin receptor expression in Graves' orbital adipose/connective tissues: potential autoantigen in Graves' ophthalmopathy

1 reference

12 December 2020

Development of an animal model of autoimmune thyroid eye disease

1 reference

12 December 2020

Differentiation of human orbital preadipocyte fibroblasts induces expression of functional thyrotropin receptor

1 reference

12 December 2020

Expression of thyrotropin-receptor mRNA in healthy and Graves' disease retro-orbital tissue

1 reference

12 December 2020

10.1016/J.AJO.2006.02.047

Identifiers

DOI

1 reference

14 August 2017

1 reference

14 August 2017

PubMed publication ID

16815265

1 reference